Cysview Side Effects
Generic name: hexaminolevulinate
Medically reviewed by Drugs.com. Last updated on Aug 22, 2023.
Note: This document contains side effect information about hexaminolevulinate. Some dosage forms listed on this page may not apply to the brand name Cysview.
Applies to hexaminolevulinate: urinary bladder powder for solution.
Serious side effects of Cysview
Along with its needed effects, hexaminolevulinate (the active ingredient contained in Cysview) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking hexaminolevulinate:
More common
- Blood in the urine
- burning sensation while urinating
- difficult or painful urination
- frequent urge to urinate
- lower stomach pain or spasm
Incidence not known
- Bloody or cloudy urine
- cough
- difficulty with breathing or swallowing
- dizziness
- fast heartbeat
- fever
- hives, itching, skin rash
- nausea
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- reddening of the skin, especially around the ears
- tightness in the chest
- unusual tiredness or weakness
For Healthcare Professionals
Applies to hexaminolevulinate: intravesical powder for reconstitution.
Hematologic
Uncommon (0.1% to 1%): White blood cell count increased, anemia[Ref]
Hypersensitivity
Frequency not reported: Hypersensitivity reaction, anaphylactoid shock[Ref]
Immunologic
Uncommon (0.1% to 1%): Sepsis[Ref]
Musculoskeletal
Uncommon (0.1% to 1%): Back pain[Ref]
Metabolic
Uncommon (0.1% to 1%): Gout[Ref]
Psychiatric
Uncommon (0.1% to 1%): Insomnia[Ref]
Genitourinary
Common (1% to 10%): Bladder spasm, bladder pain, dysuria, urinary retention, hematuria
Uncommon (0.1% to 1%): Urethral pain, pollakiuria, micturition urgency, urinary tract disorder, balanitis, cystitis, urinary tract infection
Postmarketing reports: Abnormal urinalysis[Ref]
Hepatic
Uncommon (0.1% to 1%): Increased serum bilirubin, hepatic enzyme increased[Ref]
Other
Common (1% to 10%): Pyrexia, post-procedural pain, post-operative fever[Ref]
Nervous system
Common (1% to 10%): Headache[Ref]
Gastrointestinal
Common (1% to 10%): Nausea, vomiting, constipation, diarrhea[Ref]
More about Cysview (hexaminolevulinate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: malignancy photosensitizers
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
References
1. Cerner Multum, Inc. UK Summary of Product Characteristics.
2. Cerner Multum, Inc. Australian Product Information.
3. Product Information. Cysview (hexaminolevulinate). Photocure Inc. 2014.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
